Artelo Biosciences Inc.

Last updated September 27, 2026

Organization details

Legal name
Artelo Biosciences Inc.
Former names
Reactive Medical INC. Knight Knox Development Corp.
Ownership
Public
Status
Active
SIC code
2834 — Pharmaceutical Preparations
Jurisdiction of incorporation
Nevada
Headquarters city
Solana Beach
Headquarters state / province
California
Headquarters country
United States
Fiscal year end
December
Ticker symbol
ARTL
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001621221
EIN
33-1220924

Board of directors

Chief executives

Gregory D. Gorgas · Pres, CEO, CFO, Treas & Secr
Dates unknown

Director election results

Annual meeting of January 30, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

2 of this board's directors also sit on 4 other boards.

Network of Artelo Biosciences Inc.'s board connections Halozyme Therapeutics Inc. Halozyme Therapeutics... Sutro Biopharma Inc. Sutro Biopharma Inc. TuHURA Biosciences Inc. TuHURA Biosciences Inc... Zevra Therapeutics Inc. Zevra Therapeutics Inc... Connie Matsui Connie Matsui Tamara A. Favorito Tamara A. Favorito Artelo Biosciences Inc.
Shared director Other board Same sector

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.